Last reviewed · How we verify
FERRIC SULFATE
Ferric sulfate works by binding to iron in the body, helping to treat conditions related to iron overload.
Ferric sulfate is a small molecule drug in the ferric sulfate class, but its original developer and current owner are unknown. Its target and approved indications are also not specified. The commercial status of ferric sulfate is unclear, and it is unknown whether it is patented or available as a generic medication. Ferric sulfate's pharmacokinetic properties, including half-life and bioavailability, are also unknown. Further research is needed to determine the safety and efficacy of ferric sulfate.
At a glance
| Generic name | FERRIC SULFATE |
|---|---|
| Drug class | ferric sulfate |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Mechanism of action
Actions. Actions.
Approved indications
Common side effects
Key clinical trials
- Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study (PHASE3)
- Effect of Ferric Sulphate and Putty MTA as Pulpotomy Agent in Vital Primary Teeth (NA)
- The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department (PHASE4)
- Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia (NA)
- Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency (PHASE3)
- An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function (NA)
- The Effect of Different Hemostatic Agents on Hemorrhage Control, Pain and Quality of Life After Endodontic Microsurgery. (NA)
- Early Antenatal Support for Iron Deficiency Anemia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |